HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

William Kemnitzer Selected Research

5- (3- chlorothiophen- 2- yl)- 3- (5- chloropyridin- 2- yl)- 1,2,4- oxadiazole

8/2005Discovery and structure-activity relationship of 3-aryl-5-aryl-1,2,4-oxadiazoles as a new series of apoptosis inducers and potential anticancer agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


William Kemnitzer Research Topics

Disease

6Neoplasms (Cancer)
07/2009 - 12/2004
4Breast Neoplasms (Breast Cancer)
07/2009 - 12/2004
3Hepatocellular Carcinoma (Hepatoma)
07/2009 - 12/2008
3Colonic Neoplasms (Colon Cancer)
07/2009 - 12/2008
1Severe Acute Respiratory Syndrome
02/2006

Drug/Important Bio-Agent (IBA)

5CaspasesIBA
07/2009 - 12/2004
2Paclitaxel (Taxol)FDA LinkGeneric
05/2009 - 12/2004
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2009 - 12/2004
1crolibulinIBA
05/2009
1quinolineIBA
12/2008
1KetonesIBA
02/2006
15- (3- chlorothiophen- 2- yl)- 3- (5- chloropyridin- 2- yl)- 1,2,4- oxadiazoleIBA
08/2005

Therapy/Procedure

1Therapeutics
05/2009